Derek Pain: SnackTime's tasty takeover brings hope of bigger things to come

No Pain, No Gain

SnackTime appears to have pulled off a remarkable deal, although the stock market greeted its initiative with complete indifference. It is, in effect, a reverse takeover, costing nearly £11m against the £10.3m vending machine group's capitalisation.

The expansion-hungry snacks business is acquiring Vendia, which spreads nationally operating under four brand names. The logic of the deal seems to be that Vendia is big in hot drinks whereas SnackTime is still largely a cold drinks supplier. A happy mix, then. It is – almost – an all-paper deal with shares and warrants, with lock-ins, making up all but £500,000 of the consideration. And even that cash outlay is on a deferred basis. The stock market was, however, completely unimpressed, leaving the shares, as I write, unchanged at 137.5p

SnackTime, recruited to the No Pain, No Gain portfolio a year ago, has long been keen to add hot drinks to its menu. It has a fledgling operation created from scratch but no doubt sees Vendia as a quick-fix solution. As a result of this deal, the enlarged group will have 30,000 customers and will rank as the nation's fourth-largest drinks and snacks vending machine operator.

By SnackTime standards it is clearly a hearty meal. That, of course, could be a problem. The danger of acute indigestion must be high. Blair Jenkins, the chief executive, recognises that possible problems could lurk and has instituted a series of management changes. From the day it became a portfolio constituent, SnackTime has made no secret of its expansion agenda. Earlier this year, it paid £1.5m for what was then described as its biggest rival, MBM Systems. It makes no secret of its desire to become Europe's biggest drink and snack vending machine operator.

Last year, it achieved a sharp increase in profits, but in strict terms suffered a loss. Reorganisation and rebranding costs, plus setting up a marketing department, did the damage. Perhaps that is why Mr Jenkins does not expect the latest deal to be earnings-enhancing until the year ending March 2012.

Vendia shareholders will control 29 per cent of the enlarged capital, sharply reducing the stake of Elderstreet, the investment group that has a long involvement.

Another constituent, Lighthouse, has produced interim results. The figures were encouraging with revenue up 11 per cent and pre-tax profits emerging at £117,000 against £56,000. The accountancy and wealth management group has £12m stashed away in the bank. I regard Lighthouse's low share price as one of the mysteries of the stock market. It is profitable, dividend paying (a 0.12p interim will be distributed next month) and has sufficient cash in the bank to cover its capitalisation.

Other portfolio members have been making waves. Booker, the cash-and-carry chain, indicated that interim results will be strong by revealing that first-half sales were up 5.5 per cent with a 6.1 per cent gain in the second quarter. It has £10.1m in cash compared with a £4m debt this time last year. Stockbroker Evolution Securities has a buy recommendation on the shares. And Mears, the support services group, has, intriguingly, teamed up with British Gas to provide energy-efficient social housing. The first deal should be clinched towards the end of the year.

Mears has also acquired social housing contracts previously conducted by its failed rival, Connaught. Most of the stricken group's arrangements went to construction group Morgan Sindall. Whether the new providers will make much cash out of the contracts remains to be seen. After all, Connaught seems to have excelled in signing up ruinous deals.

The portfolio's two blue-chips continue to receive stockbroker support. Charles Stanley has an "accumulate" tag on Whitbread and Seymour Pierce is still running with a 320p target on security group G4S.

It has been a mixed few weeks for G4S. The South African operation has been extended through a modest buy but in the US it lost a Nasa contract covering 14 installations. It still has contracts for six Nasa centres. And the powerful institutional investor, Credit Suisse, seems to have given up on the security giant. It once had more than 8 per cent but has now declared it no longer has a notifiable interest – so its stake is certainly below 3 per cent and I would guess is down to zilch.

Independent Partners; Do you need financial advice on your investments, pension or insurance? Book a free consultation with an independent Financial Adviser at VouchedFor.co.uk

Arts and Entertainment
Attenborough with the primates
tvWhy BBC producers didn't want to broadcast Sir David Attenborough's famed Rwandan encounter
News
Campbell: ‘Sometimes you have to be economical with the truth’
newsFormer spin doctor says MPs should study tactics of leading sports figures like José Mourinho
Sport
football
Life and Style
Agretti is often compared to its relative, samphire, though is closer in taste to spinach
food + drink
News
Kelly Osbourne will play a flight attendant in Sharknado 2
people
News
Down-to-earth: Winstone isn't one for considering his 'legacy'
people
News
The dress can be seen in different colours
i100
Sport
Wes Brown is sent-off
football
Voices
Lance Corporal Joshua Leakey VC
voicesBeware of imitations, but the words of the soldier awarded the Victoria Cross were the real thing, says DJ Taylor
Life and Style
Alexander McQueen's AW 2009/10 collection during Paris Fashion Week
fashionMeet the collaborators who helped create the late designer’s notorious spectacles
Finacial products from our partners
Property search
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

ES Rentals

    iJobs Job Widget
    iJobs Money & Business

    SThree: HR Benefits Manager

    £40000 - £50000 per annum + pro rata: SThree: SThree Group have been well esta...

    Recruitment Genius: Office Manager / Financial Services

    £30000 - £37000 per annum: Recruitment Genius: Established in 1999, a highly r...

    Jemma Gent: Year End Accountant

    £250-£300 Day Rate: Jemma Gent: Are you a qualified accountant with strong exp...

    Jemma Gent: Management Accountant

    £230 - £260 Day Rate: Jemma Gent: Do you want to stamp your footprint in histo...

    Day In a Page

    War with Isis: Fears that the looming battle for Mosul will unleash 'a million refugees'

    The battle for Mosul will unleash 'a million refugees'

    Aid agencies prepare for vast exodus following planned Iraqi offensive against the Isis-held city, reports Patrick Cockburn
    Yvette Cooper: We can't lose the election. There's too much on the line

    Yvette Cooper: We can't lose the election. There's too much on the line

    The shadow Home Secretary on fighting radical Islam, protecting children, and why anyone in Labour who's thinking beyond May must 'sort themselves out'
    A bad week for the Greens: Leader Natalie Bennett's 'car crash' radio interview is followed by Brighton council's failure to set a budget due to infighting

    It's not easy being Green

    After a bad week in which its leader had a public meltdown and its only city council couldn't agree on a budget vote, what next for the alternative party? It's over to Caroline Lucas to find out
    Gorillas nearly missed: BBC producers didn't want to broadcast Sir David Attenborough's famed Rwandan encounter

    Gorillas nearly missed

    BBC producers didn't want to broadcast Sir David Attenborough's famed Rwandan encounter
    Downton Abbey effect sees impoverished Italian nobles inspired to open their doors to paying guests for up to €650 a night

    The Downton Abbey effect

    Impoverished Italian nobles are opening their doors to paying guests, inspired by the TV drama
    China's wild panda numbers have increased by 17% since 2003, new census reveals

    China's wild panda numbers on the up

    New census reveals 17% since 2003
    Barbara Woodward: Britain's first female ambassador to China intends to forge strong links with the growing economic superpower

    Our woman in Beijing builds a new relationship

    Britain's first female ambassador to China intends to forge strong links with growing economic power
    Courage is rare. True humility is even rarer. But the only British soldier to be awarded the Victoria Cross in Afghanistan has both

    Courage is rare. True humility is even rarer

    Beware of imitations, but the words of the soldier awarded the Victoria Cross were the real thing, says DJ Taylor
    Alexander McQueen: The catwalk was a stage for the designer's astonishing and troubling vision

    Alexander McQueen's astonishing vision

    Ahead of a major retrospective, Alexander Fury talks to the collaborators who helped create the late designer's notorious spectacle
    New BBC series savours half a century of food in Britain, from Vesta curries to nouvelle cuisine

    Dinner through the decades

    A new BBC series challenged Brandon Robshaw and his family to eat their way from the 1950s to the 1990s
    Philippa Perry interview: The psychotherapist on McDonald's, fancy specs and meeting Grayson Perry on an evening course

    Philippa Perry interview

    The psychotherapist on McDonald's, fancy specs and meeting Grayson Perry on an evening course
    Bill Granger recipes: Our chef recreates the exoticism of the Indonesian stir-fry

    Bill Granger's Indonesian stir-fry recipes

    Our chef was inspired by the south-east Asian cuisine he encountered as a teenager
    Chelsea vs Tottenham: Harry Kane was at Wembley to see Spurs beat the Blues and win the Capital One Cup - now he's their great hope

    Harry Kane interview

    The striker was at Wembley to see Spurs beat the Blues and win the Capital One Cup - now he's their great hope
    The Last Word: For the good of the game: why on earth don’t we leave Fifa?

    Michael Calvin's Last Word

    For the good of the game: why on earth don’t we leave Fifa?
    HIV pill: Scientists hail discovery of 'game-changer' that cuts the risk of infection among gay men by 86%

    Scientists hail daily pill that protects against HIV infection

    Breakthrough in battle against global scourge – but will the NHS pay for it?